Sarah Cannon (Tennessee Oncology - Nashville) is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.
Sarah Cannon (Tennessee Oncology - Nashville) has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Extensive-stage Small-cell Lung Cancer, Advanced Colorectal Cancer, Colorectal Cancer Stage II.
Sponsors: Daiichi Sankyo, BioNTech SE.
Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon (Tennessee Oncology - Nashville) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon (Tennessee Oncology - Nashville) has 3 clinical trials on record, with 2 currently active. Their work covers Extensive-stage Small-cell Lung Cancer, Advanced Colorectal Cancer, Colorectal Cancer Stage II.
Sarah Cannon (Tennessee Oncology - Nashville) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.